Literature DB >> 5694947

Dornase aerosol effect on sputum viscosity in cases of cystic fibrosis.

J Lieberman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5694947

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  17 in total

Review 1.  Cell and gene therapy for genetic diseases: inherited disorders affecting the lung and those mimicking sudden infant death syndrome.

Authors:  Allison M Keeler; Terence R Flotte
Journal:  Hum Gene Ther       Date:  2012-06       Impact factor: 5.695

2.  Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.

Authors:  C M Costello; C M O'Connor; G A Finlay; P Shiels; M X FitzGerald; J P Hayes
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

Review 3.  Polyelectrolyte properties of filamentous biopolymers and their consequences in biological fluids.

Authors:  Paul A Janmey; David R Slochower; Yu-Hsiu Wang; Qi Wen; Andrejs Cēbers
Journal:  Soft Matter       Date:  2014-03-14       Impact factor: 3.679

4.  Extracellular chromatin is an important mediator of ischemic stroke in mice.

Authors:  Simon F De Meyer; Georgette L Suidan; Tobias A Fuchs; Marc Monestier; Denisa D Wagner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

Review 5.  The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.

Authors:  M S Zach
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

Review 6.  Human recombinant DNase in cystic fibrosis.

Authors:  A H Thomson
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

7.  Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

Authors:  S Shak; D J Capon; R Hellmiss; S A Marsters; C L Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 8.  Timing of dornase alfa inhalation for cystic fibrosis.

Authors:  Ruth Dentice; Mark Elkins
Journal:  Cochrane Database Syst Rev       Date:  2016-07-26

Review 9.  Quality of life in children and adolescents with cystic fibrosis: implications for optimizing treatments and clinical trial design.

Authors:  Janice Abbott; Louise Gee
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

10.  Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis.

Authors:  Tacjana Pressler
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.